Xd. You et al., IN-VITRO ACTIVITIES OF PAROMOMYCIN AND LASALOCID EVALUATED IN COMBINATION AGAINST CRYPTOSPORIDIUM-PARVUM, Journal of antimicrobial chemotherapy, 41(2), 1998, pp. 293-296
Using a chemiluminescence immunoassay, paromomycin and lasalocid were
shown to inhibit Cryptosporidium parvum growth in Madin-Darby canine k
idney cells in a concentration-dependent manner. The median effective
concentrations (EC(50)s) for paromomycin and lasalocid were 1184 mg/L
and 0.4 mg/L, respectively. Neither drug was cytotoxic to host cells a
t concentrations up to five times their EC(50)s. Drug combination stud
ies were conducted and the resulting data were analysed by the median-
effect principle and combination index method. Statistically significa
nt synergy was observed when combinations of paromomycin and lasalocid
were used at ratios of 5000:1 and 2500:1. A possible mechanism for sy
nergy is discussed.